Compounded vs FDA-Approved GLP-1 Drugs
The regulatory distinction every GLP-1 shopper should understand before comparing prices or providers.
Medical information notice: This page is educational, not medical advice. Compounded medications are not FDA-approved. A licensed clinician should determine whether prescription treatment is appropriate for you.
Key points
- FDA-approved drugs undergo FDA review for safety, effectiveness and quality before marketing.
- Compounded drugs are not FDA-approved and do not undergo that premarket review.
- FDA says compounded drugs can serve patient needs in certain circumstances but has warned against misleading mass marketing.
The distinction in one table
| FDA-approved drug | Compounded drug | |
|---|---|---|
| FDA premarket approval | Yes, for the approved product and indication | No |
| FDA premarket review of safety/effectiveness/quality | Yes | No |
| Patient-specific compounding pathway | Not the defining pathway | May apply under federal/state compounding rules |
What to verify before making a decision
Confirm the exact product, FDA approval status, prescriber, dispensing pharmacy, total amount billed today, renewal terms, cancellation rules and available clinical follow-up. Program terms can change, so merchant-specific claims should be checked at the source.
Related guides
Sources & update standard
Merchant-specific claims are based on HealthRX’s currently published materials. Regulatory distinctions are checked against FDA materials. We date-stamp substantive reviews because pricing, supply conditions and compounding policy can change.